Clinical features and inflammatory markers in pediatric pneumonia: a prospective study
- 461 Downloads
In this prospective, observational study on previously healthy children <18 years, we aimed to study the diagnostic ability of clinical features and inflammatory markers to (i) predict pathologic chest radiography in suspected pneumonia and (ii) differentiate etiology in radiological proven pneumonia. In 394 cases of suspected pneumonia, 265 (67%) had radiographs consistent with pneumonia; 34/265 had proof of bacterial etiology. Of the cases, 86.5% had received pneumococcal conjugate vaccine. In suspected pneumonia, positive chest radiography was significantly associated with increasing C-reactive protein (CRP) values, higher age, and SpO2 ≤92% in multivariate logistic regression, OR 1.06 (95% CI 1.03 to 1.09), OR 1.09 (95% CI 1.00 to1.18), and OR 2.71 (95% CI 1.42 to 5.18), respectively. In proven pneumonia, bacterial pneumonia was significantly differentiated from viral/atypical pneumonia by increasing CRP values and SpO2 >92% in multivariate logistic regression, OR 1.09 (95% CI 1.05 to 1.14) and OR 0.23 (95% CI 0.06 to 0.82), respectively. Combining high CRP values (>80 mg/L) and elevated white blood cell (WBC) count provided specificity >85%, positive likelihood ratios >3, but sensitivity <46% for both radiographic proven and bacterial pneumonia.
What is Known:
• Pneumonia is recommended to be a clinical diagnosis, and neither clinical features nor inflammatory markers can reliably distinguish etiology.
• The etiology of pneumonia has changed after routine pneumococcal conjugate vaccine.
What is New:
• High CRP and WBC counts were associated with infiltrates in children with suspected pneumonia and with bacterial infection in proven pneumonia.
• In the post-pneumococcal vaccination era, viral etiology is expected, and in cases of pneumonia with low CRP and WBC counts, a watch-and-wait strategy for antibiotic treatment may be applied.
KeywordsPneumonia Clinical features Inflammatory markers Pneumococcal vaccination
Acute lower respiratory tract infection
Area under the curve
Polymerase chain reaction
Receiver operating characteristics
White blood cells
We are grateful to all participating children and their parents and nurses and doctors on call for recruiting patients and collecting data. We thank Drs. R Bull and R Grotli at the Department for Radiology, Akershus University Hospital, for performing the radiological examinations; Dr. I Aaberge and A Aase for the pneumococcal serological analyses at the Department of Bacteriology and Immunology, the Norwegian Institute for Public Health; and Dr. Line Sletner at our department for the advise on statistical analyses and staff at the laboratories at Akershus University Hospital for performing the laboratory analyses.
All authors provided substantial contributions to the study’s conception and design and acquisition, analysis, or interpretation of the data.
Drs. Berg, Inchley, Fjaerli, and Nakstad executed the clinical part of the work.
Dr. Leegaard was responsible for the microbiological laboratory analyses.
Dr. Lindbaek was responsible for the primary care part of the study.
Dr. Berg drafted the initial manuscript, and all other authors revised it critically for important intellectual content. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and approved by both the Regional Ethics Committee and the local Data Protection Officer. Furthermore, the study was in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Source of funding
The study was supported by research grants from Akershus University Hospital and South-Eastern Norway Regional Health Authority and grants from the Grimsgaard Foundation and the Norwegian Organization for Surveillance of Antimicrobial Resistance.
- 1.Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S, Minodier P, Dommergues MA, Hees L, Gillet Y, Craiu I, Zenkhri F, Dubos F, Guen CG, Launay E, Martinot A, Cohen R (2014) Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis 58(7):918–924. doi: 10.1093/cid/ciu006 CrossRefPubMedGoogle Scholar
- 4.Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT, Pediatric Infectious Diseases S, the Infectious Diseases Society of A (2011) The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53(7):e25–e76. doi: 10.1093/cid/cir531 CrossRefPubMedGoogle Scholar
- 5.Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M, Greenberg D, Lagos R, Lucero M, Madhi SA, O’Brien KL, Obaro S, Steinhoff MC (2005) Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 83(5):353–359PubMedPubMedCentralGoogle Scholar
- 7.Craig JC, Williams GJ, Jones M, Codarini M, Macaskill P, Hayen A, Irwig L, Fitzgerald DA, Isaacs D, McCaskill M (2010) The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ 340:c1594. doi: 10.1136/bmj.c1594 CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Esposito S, Bosis S, Cavagna R, Faelli N, Begliatti E, Marchisio P, Blasi F, Bianchi C, Principi N (2002) Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2–5 years of age with community-acquired pneumonia. Clin Infect Dis 35(11):1345–1352. doi: 10.1086/344191 CrossRefPubMedGoogle Scholar
- 12.Galetto-Lacour A, Alcoba G, Posfay-Barbe KM, Cevey-Macherel M, Gehri M, Ochs MM, Brookes RH, Siegrist CA, Gervaix A (2013) Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children. Pediatr Infect Dis J 32(11):1175–1179. doi: 10.1097/INF.0b013e31829ba62a CrossRefPubMedGoogle Scholar
- 16.Hazir T, Nisar YB, Qazi SA, Khan SF, Raza M, Zameer S, Masood SA (2006) Chest radiography in children aged 2–59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ 333(7569):629. doi: 10.1136/bmj.38915.673322.80 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Hinchliffe R (1992) Reference values. In: Lilleyman J, Hann I (eds) Pediatric hematology, 2nd edn. Churchill Livingstone, Edinburgh, pp 1–22Google Scholar
- 19.Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L, Team CES (2015) Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372(9):835–845. doi: 10.1056/NEJMoa1405870 CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Oostenbrink R, Thompson M, Lakhanpaul M, Steyerberg EW, Coad N, Moll HA (2013) Children with fever and cough at emergency care: diagnostic accuracy of a clinical model to identify children at low risk of pneumonia. Eur J Emerg Med 20(4):273–280. doi: 10.1097/MEJ.0b013e32835771fd CrossRefPubMedGoogle Scholar
- 38.Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B (2012) The Norwegian immunisation register—SYSVAK. Euro Surveill 17 (16)Google Scholar